Naltrexone–bupropion for managing overweight and obesity

Supporting evidence

• Review decision

• Review decision – January 2020

• Review proposal paper (PDF 273 KB)

  Published:

  21 January 2020

• Stakeholder list (PDF 184 KB)

  Published:

  21 January 2020